SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-030591
Filing Date
2022-03-04
Accepted
2022-03-04 16:06:08
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tm228110-1_s3.htm S-3 406313
2 EXHIBIT 4.2 tm228110d2_ex4-2.htm EX-4.2 369105
3 EXHIBIT 4.4 tm228110d2_ex4-4.htm EX-4.4 121486
4 EXHIBIT 4.5 tm228110d2_ex4-5.htm EX-4.5 120438
5 EXHIBIT 4.6 tm228110d2_ex4-6.htm EX-4.6 110739
6 EXHIBIT 5.1 tm228110d2_ex5-1.htm EX-5.1 26293
7 EXHIBIT 23.1 tm228110d2_ex23-1.htm EX-23.1 2352
8 EX-FILING FEES tm228110d2_ex107.htm EX-FILING FEES 49450
9 GRAPHIC lg_glycomimeincinno-4clr.jpg GRAPHIC 29834
10 GRAPHIC tm228110d2_ex5-1img001.jpg GRAPHIC 2754
  Complete submission text file 0001104659-22-030591.txt   1252335
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263297 | Film No.: 22714066
SIC: 2834 Pharmaceutical Preparations